Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 29, 2023 - Biogen announced the FDA approval of Tofidence (tocilizumab-bavi), biosimilar to Genentech’s Actemra® (tocilizumab).
Download PDF
Return to publications
